Vertex Pharmaceuticals in Boston seeks a Senior Director, US Market Access Strategy to lead payer strategy, pricing, contracting, and evidence development for povetacicept (POVE) in IgAN and future indications.
You will guide a cross‑functional team, align launch readiness across US Market Access, and build a compelling payer value proposition to ensure timely patient access and favorable reimbursement.
#J-18808-LjbffrUS Market Access Director — Povetacicept IgAN Launch in boston at Unknown Company
This position is listed as contract and onsite.